19 results  1 of 1 

1 Beneficial effects of posttransplant dipeptidyl peptidase-4 inhibitor administration after pancreas transplantation to improve β cell function
Hye-Won Jang, Chang Hee Jung, Youngmin Ko, Seong Jun Lim, Hye Eun Kwon, Joo Hee Jung, Hyunwook Kwon, Young Hoon Kim, Sung Shin
Ann Surg Treat Res.2021;101(3):187-196.   Published online 2021 August 31     DOI: http://dx.doi.org/10.4174/astr.2021.101.3.187
      
2 Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study)
Ji Cheol Bae, Soo Heon Kwak, Hyun Jin Kim, Sang-Yong Kim, You-Cheol Hwang, Sunghwan Suh, Bok Jin Hyun, Ji Eun Cha, Jong Chul Won, Jae Hyeon Kim
Diabetes Metab J.2022;46(1):81-92.   Published online 2021 June 16     DOI: http://dx.doi.org/10.4093/dmj.2021.0016
      
3 Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
Sang Youl Rhee, Jeongwoo Lee, Hyewon Nam, Dae-Sung Kyoung, Dong Wook Shin, Dae Jung Kim
Diabetes Metab J.2021;45(2):251-259.   Published online 2021 March 5     DOI: http://dx.doi.org/10.4093/dmj.2020.0206
      
4 Efficacy of evogliptin and cenicriviroc against nonalcoholic steatohepatitis in mice: a comparative study
Zheng Wang, Hansu Park, Eun Ju Bae
Korean J Physiol Pharmacol.2019;23(6):459-466.   Published online 2019 October 24     DOI: http://dx.doi.org/10.4196/kjpp.2019.23.6.459
      
5 Effect of gemigliptin on cardiac ischemia/reperfusion and spontaneous hypertensive rat models
Dae-Hwan Nam, Jinsook Park, Sun-Hyun Park, Ki-Suk Kim, Eun Bok Baek
Korean J Physiol Pharmacol.2019;23(5):329-334.   Published online 2019 August 26     DOI: http://dx.doi.org/10.4196/kjpp.2019.23.5.329
      
6 Potentiation of endothelium-dependent vasorelaxation of mesenteric arteries from spontaneously hypertensive rats by gemigliptin, a dipeptidyl peptidase-4 inhibitor class of anti-diabetic drug
Hae Jin Kim, Eun Bok Baek, Sung Joon Kim
Korean J Physiol Pharmacol.2018;22(6):713-719.   Published online 2018 October 25     DOI: http://dx.doi.org/10.4196/kjpp.2018.22.6.713
      
7 Soluble Dipeptidyl Peptidase-4 Levels Are Associated with Decreased Renal Function in Patients with Type 2 Diabetes Mellitus
Eun-Hee Cho, Sang-Wook Kim
Diabetes Metab J.2019;43(1):97-104.   Published online 2018 October 8     DOI: http://dx.doi.org/10.4093/dmj.2018.0030
      
8 Sodium butyrate has context-dependent actions on dipeptidyl peptidase-4 and other metabolic parameters
Eun-Sol Lee, Dong-Sung Lee, Prakash Raj Pandeya, Youn-Chul Kim, Dae-Gil Kang, Ho-Sub Lee, Byung-Chul Oh, Dae Ho Lee
Korean J Physiol Pharmacol.2017;21(5):519-529.   Published online 2017 August 22     DOI: http://dx.doi.org/10.4196/kjpp.2017.21.5.519
      
9 An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
Suk Chon, Jean-François Gautier
Diabetes Metab J.2016;40(2):99-114.   Published online 2016 April 25     DOI: http://dx.doi.org/10.4093/dmj.2016.40.2.99
      
10 Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
Jong Ho Kim, Sang Soo Kim, Hong Sun Baek, In Kyu Lee, Dong Jin Chung, Ho Sang Sohn, Hak Yeon Bae, Mi Kyung Kim, Jeong Hyun Park, Young Sik Choi, Young Il Kim, Jong Ryeal Hahm, Chang Won Lee, Sung Rae Jo, Mi Kyung Park, Kwang Jae Lee, In Joo Kim
Diabetes Metab J.2016;40(3):230-239.   Published online 2016 April 5     DOI: http://dx.doi.org/10.4093/dmj.2016.40.3.230
      
11 High Levels of Serum DPP-4 Activity Are Associated with Low Bone Mineral Density in Obese Postmenopausal Women
Sang-Wook Kim, Eun-Hee Cho
Endocrinol Metab.2016;31(1):93-99.   Published online 2016 March 16     DOI: http://dx.doi.org/10.3803/EnM.2016.31.1.93
      
12 Predictive Factors for the Therapeutic Response to Concomitant Treatment with DPP-4 Inhibitors in Type 2 Diabetes with Short-Term Follow-Up
Jong-Ha Baek, Bo Ra Kim, Jeong Woo Hong, Soo Kyoung Kim, Jung Hwa Jung, Jaehoon Jung, Jong Ryeal Hahm
Kosin Med J.2016;31(2):146-156.   Published online 2016 January 20     DOI: http://dx.doi.org/10.7180/kmj.2016.31.2.146
   
13 Effect of Dipeptidyl Peptidase-4 Inhibitor on All-Cause Mortality and Coronary Revascularization in Diabetic Patients
Hyo Eun Park, Jooyeong Jeon, In-Chang Hwang, Jidong Sung, Seung-Pyo Lee, Hyung-Kwan Kim, Goo-Yeong Cho, Dae-Won Sohn, Yong-Jin Kim
J Cardiovasc Ultrasound.2015;23(4):233-243.   Published online 2015 December 30     DOI: http://dx.doi.org/10.4250/jcu.2015.23.4.233
      
14 Dipeptidyl Peptidase 4 Inhibitors and the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Tale of Three Studies
Jang Won Son, Sungrae Kim
Diabetes Metab J.2015;39(5):373-383.   Published online 2015 October 22     DOI: http://dx.doi.org/10.4093/dmj.2015.39.5.373
      
15 Dipeptidyl Peptidase 10, a Novel Prognostic Marker in Colorectal Cancer
Heae Surng Park, Hyun Yang Yeo, Hee Jin Chang, Kyung-Hee Kim, Ji Won Park, Byung Chang Kim, Ji Yeon Baek, Sun Young Kim, Dae Yong Kim
Yonsei Med J.2013;54(6):1362-1369.   Published online 2013 October 1     DOI: http://dx.doi.org/10.3349/ymj.2013.54.6.1362
      
16 Clinical Characteristics of the Responders to Dipeptidyl Peptidase-4 Inhibitors in Korean Subjects with Type 2 Diabetes
Tae Jung Oh, Hye Seung Jung, Jae Hyun Bae, Yeong Gi Kim, Kyeong Seon Park, Young Min Cho, Kyong Soo Park, Seong Yeon Kim
J Korean Med Sci.2013;28(6):881-887.   Published online 2013 June 3     DOI: http://dx.doi.org/10.3346/jkms.2013.28.6.881
      
17 Predictive Clinical Parameters and Glycemic Efficacy of Vildagliptin Treatment in Korean Subjects with Type 2 Diabetes
Jin-Sun Chang, Juyoung Shin, Hun-Sung Kim, Kyung-Hee Kim, Jeong-Ah Shin, Kun-Ho Yoon, Bong-Yun Cha, Ho-Young Son, Jae-Hyoung Cho
Diabetes Metab J.2013;37(1):72-80.   Published online 2013 February 15     DOI: http://dx.doi.org/10.4093/dmj.2013.37.1.72
      
18 The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes
Yoshiaki Kubota, Masaaki Miyamoto, Gen Takagi, Takeshi Ikeda, Sonoko Kirinoki-Ichikawa, Kotoko Tanaka, Kyoichi Mizuno
J Korean Med Sci.2012;27(11):1364-1370.   Published online 2012 October 30     DOI: http://dx.doi.org/10.3346/jkms.2012.27.11.1364
      
19 Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
Jae-Geun Lee, Dong Gu Kang, Jung Re Yu, Young Ree Kim, Jin Soek Kim, Gwan Pyo Koh, Dae Ho Lee
Diabetes Metab J.2011;35(2):149-158.   Published online 2011 April 30     DOI: http://dx.doi.org/10.4093/dmj.2011.35.2.149
      

 1 of 1